Theator

Surgical Intelligence Platform

Health Tech & Life Sciences
Private
Follow

Company Overview

Snapshot

Founded in April 2018 by Tamir Wolf and Dotan Asselmann, Theator operates with 51–200 employees. The company has raised $43.1 million across 3 funding rounds from 12 investors, with Insight Partners leading a Series A extension round in July 2022.

Business overview

Theator develops a Surgical Intelligence platform that leverages visual AI, machine learning, and computer vision to analyze surgical video data. This technology is designed to identify, optimize, and scale best practices among surgeons, aiming to improve performance and patient outcomes. The company's core product transforms routine video capture and analysis in surgical care into actionable insights, serving the healthcare and life sciences sectors, specifically healthcare providers.

Strategic signal

In July 2022, Theator secured a $24 million Series A extension round led by Insight Partners. This significant capital infusion signals strong investor confidence in the company's AI-driven surgical intelligence platform and its potential for commercial expansion, indicating a clear growth trajectory for the company in the digital health market.

Log in to access full profile

Company Intelligence Q&A

What was Theator's most recent funding activity?
Theator secured an extension to its Series A funding round in July 2022, raising $24 million. This round was led by Insight Partners and included participation from Neil Hunt.
Which investors participated in Theator's Series A funding round in February 2021?
In February 2021, Theator closed a Series A funding round with Insight Partners as the lead investor.
What strategic partnership did Theator announce in July 2021?
In July 2021, Theator partnered with Mayo Clinic to integrate its surgical intelligence platform into the clinic's urology and gynecology departments, focusing on improving surgeon performance through AI and video analytics.
What recognition did Theator receive in December 2021?
In December 2021, Theator was named to the 2021 CB Insights Digital Health 150, recognizing it as one of the most innovative digital health startups.
When did Theator appoint its Chief Commercial Officer?
Theator appointed Kavi Vyas as its Chief Commercial Officer in August 2021, aiming to increase global visibility and accelerate the institutional adoption of its platform.
Log in to access full profile